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Introduction. Collapsing glomerulopathy (CG) is a rare form of glomerular injury.
Although commonly associated with human immunodeficiency virus (HIV) infection, it can
occur in association with systemic lupus erythematosus (SLE).
Case Report. We present the case of a 50-year-old man, with chronic kidney disease
secondary to focal and segmental glomerulosclerosis, who received a cadaveric kidney
transplant in 2007.
There were no relevant intercurrences until May 2015, when he presented with nephrotic
range proteinuria ( 4 g/d). A graft biopsy was performed and it did not show any sig-
nificant pathological changes. In September, he developed a full nephrotic syndrome
(proteinuria 19 g/d) and a graft biopsy was repeated. CG features were evident with a rich
immunofluorescence. Antinuclear antibodies (ANA) and anti-double-stranded DNA (anti-
dsDNA) antibodies were positive; the remaining immunologic study was normal. Viral
markers for HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV) were negative.
The patient was treated with corticosteroid pulses and plasmapheresis (seven
treatments). A rapid deterioration of kidney function was seen and he became dialysis
dependent. He was discharged with a low-dose immunosuppressive treatment. In
October, he was hospitalized with diffuse alveolar hemorrhage (DAH). The auto-
immune study was repeated, revealing complement consumption and positive titers of
ANA and Anti-dsDNA antibodies. Anti-neutrophil cytoplasmic antibodies (ANCAs) and
antiglomerular basement membrane antibody (anti-GBM) were negative. Treatment
with intravenous corticosteroids, plasmapheresis, and human immunoglobulin was
ineffective and the outcome was fatal.
Conclusion. This case report highlights the possible association of CG and SLE. To our
knowledge, it is the first case of SLE presenting with CG and DAH, with the singularity of
occurring in a kidney transplant recipient receiving immunosuppression.*Address correspondence to Helena Pinto, MD, Centro Hos-
pitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto,
3000-075 Coimbra, Portugal. E-mail: helenasofiapinto@gmail.
comFOCAL segmental glomerulosclerosis (FSGS) is a his-tological pattern that may have different etiologies and
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Dowgenerally associated with human immunodeficiency virus
(HIV) infection but that can occur with other viral in-
fections, autoimmune diseases, and drugs [3]. The associa-
tion with systemic lupus erythematosus (SLE) is very
unusual [4].
Diffuse alveolar hemorrhage (DAH) is a rare but
potentially life-threatening manifestation of SLE. Despite
treatment, it remains associated with high mortality [5,6].
We present a case of a CG in a kidney transplant recip-
ient followed by DAH, both probably triggered by SLE, with
a fatal outcome.
CASE REPORT
We present the case of a white 50-year-old man, with chronic kidney
disease secondary to focal and segmental glomerulosclerosis, who
received a cadaveric kidney transplant in 2007. The induction
immunosuppression was basiliximab combined with methylpred-
nisolone pulses, mycophenolate mofetil, and tacrolimus. He was
kept under maintenance immunosuppression with tacrolimus,
mycophenolate mofetil, and prednisolone. There were no relevant
intercurrences until May 2015, when he presented with nephrotic
range proteinuria (4 g/d) and normal graft function. He was
admitted in our department and a kidney graft biopsy was per-
formed. It revealed no major pathological alterations, although it
was a nonrepresentative sample (only 3 glomeruli). The patient was
started on an angiotensin-converting enzyme inhibitor with
reasonable proteinuria control. Two months later the patient
developed full nephrotic syndrome with peripheral edema, hypo-
albuminemia, and massive proteinuria (19 g/d) and was once again
admitted in our department. The graft function was also deterio-
rated with a serum creatinine level of 1.7 mg/dL. From the
immunologic study, antinuclear antibodies (ANA) and antie
double-stranded DNA (anti-dsDNA) were positive, with titers 1:160
and 302 IU/mL, respectively. The remaining immunologic study
(anti-neutrophil cytoplasmic antibodies [ANCAs], antiphospholipid
antibodies, total complement level) was normal. Viral markers for
HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), parvovirus
B19, human cytomegalovirus (CMV), EpsteineBarr virus (EBV),
and polyomavirus (BK) were negative. The patient had a thor-
acoabdominopelvic computed tomography scan that was unre-
markable. The graft biopsy was repeated, this time with features of
CG (Fig 1). The immunofluorescence was positive, with a “full
house” pattern. The graft function began to rapidly deteriorate
and he was treated with corticosteroid pulses and startedFig 1. Light microscopy of the second graft biopsy showing features
illaries and marked hypertrophy and hyperplasia of podocytes u
(B) Segmental loss of WT-1 expression with WT-1 immunohistoch
collapse with Marinozzi silver stain (original magnification 400).
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For personal use only. No other uses without permission.plasmapheresis every other day. Graft function continued to dete-
riorate and the patient became dialysis dependent. After seven
treatments of plasmapheresis there were no signs of remission and
the proteinuria increased to 34 g/d. He was discharged on a regular
hemodialysis program with low-dose immunosuppressive treatment.
In October 2016, he was hospitalized with DAH that rapidly
evolved with severe respiratory failure and he was admitted in the
intensive care unit. The autoimmune study was repeated, revealing
complement consumption, with positive ANA and anti-dsDNA
antibodies. The ANCA and antiglomerular basement membrane
antibody (anti-GBM) were negative. Tracheobronchial aspiration
was positive for blood and negative for malignancy, bacteria,
mycobacteria, fungi, and Pneumocystis jirovecii. The patient was
treated with corticosteroid pulses, plasmapheresis, and human
immunoglobulin. There was no clinical response to treatment and
the patient was kept under mechanical ventilation and eventually
developed a ventilator-associated pneumonia with fatal outcome.DISCUSSION
FSGS is characterized by a more aggressive course in
recurrent disease, when compared with other glomerulone-
phritis, and it has an important impact on graft survival [7,8].
Treatment of recurrent post-transplantation FSGS has
not reached a consensus but, in the majority of centers, the
first therapeutic approach is the same as the one used in this
patient, with corticosteroid pulses and plasmapheresis [1,9].
Other therapeutic strategies are also available, such as use
of rituximab, but there is still no consensus on the timing,
dose, or duration of therapy [10].
The collapsing variant of FSGS is associated with a poorer
prognosis in allograft kidneys, compared with the other
variants (similar to what happens in native kidneys) [11]. CG
is generally associated with HIV infection but can occur with
other viral infections such as parvovirus B19 [12]. The
association with autoimmune diseases, such as SLE, and
drugs is also known [3]. Some anecdotal cases have been
published in the literature but in 2012 a large series of 19
cases of patients with CG and SLE or Lupus-Like Disease
was published, adding support to this association [4,13].
DAH is a rare complication in patients with SLE,
occurring in 2%e5% of cases, and is associated with a high
mortality rate. The most commonly reported therapiesof CG. (A) Segmental and global collapse of the glomerular cap-
sing Periodic acideSchiff stain (original magnification 400).
emistry stain (original magnification 400). (C) Glomerular tuff
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Dowinclude corticosteroids, plasmapheresis, cyclophosphamide,
and rituximab [5,6].
To our knowledge, this is the first case of SLE presenting
with CG and DAH. It gains an increased importance
because it occurred in a kidney transplant patient and had a
fatal outcome.
In conclusion, CG is a rare diagnosis both in native and
transplant kidneys. The majority of patients have a poor
outcome. We describe a case of CG in a kidney transplant
recipient, which presented with nephrotic syndrome and
normal graft function that rapidly deteriorated. The pres-
ence of positive auto-immunity and “full house” immuno-
fluorescence and the development of DAH favor the
diagnosis of SLE, which could have been the trigger for the
glomerular and pulmonary disease.REFERENCES
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